Skip to content
(614)355-5560
Central Region
March 5, 2024
A New Tool to Overcome Access Barriers to Spacer-Compatible Inhaled Steroids

Since the discontinuation of brand name Flovent®, there have been many challenges with patient access to spacer-compatible inhaled steroids that are appropriate for children with asthma. Even though fluticasone propionate HFA (authorized generic of Flovent®), is a covered option for Ohio Medicaid patients, there still may be shortages at the pharmacy to overcome. In response, Partners For Kids has created a pathway to guide decision-making when prescribing inhaled steroids for children.  Included in this resource is standard language that will assist with proper communication to insurance companies if a prior authorization is requested. 

If you have questions, please reach out to the Partners For Kids pharmacy team at PFKPharmacy@NationwideChildrens.org. 

Related Articles
Pharmacy Updates
December 18, 2025
Pediatric-focused Unified Preferred Drug List (UPDL)
Read More
Pharmacy Updates
December 10, 2025
RSV Toolkit
Read More
Pharmacy Updates
December 10, 2025
RSV Toolkit
Read More
Pharmacy Updates
October 1, 2025
Quarterly Updates: PFK’s Pediatric-focused Unified Preferred Drug List (UPDL)
Read More
Pharmacy Updates
October 1, 2025
Quarterly Updates: PFK’s Pediatric-focused Unified Preferred Drug List (UPDL)
Read More
Pharmacy Updates
August 20, 2025
Respiratory Syncytial Virus (RSV) Prevention Toolkit Now Available
Read More